AR005999A1 - Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos - Google Patents

Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos

Info

Publication number
AR005999A1
AR005999A1 ARP970100760A ARP970100760A AR005999A1 AR 005999 A1 AR005999 A1 AR 005999A1 AR P970100760 A ARP970100760 A AR P970100760A AR P970100760 A ARP970100760 A AR P970100760A AR 005999 A1 AR005999 A1 AR 005999A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
preparation procedure
erythromycin
medicines
compounds
Prior art date
Application number
ARP970100760A
Other languages
English (en)
Spanish (es)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of AR005999A1 publication Critical patent/AR005999A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ARP970100760A 1996-02-28 1997-02-25 Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos AR005999A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9602472A FR2745290B1 (fr) 1996-02-28 1996-02-28 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
AR005999A1 true AR005999A1 (es) 1999-07-21

Family

ID=9489659

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970100760A AR005999A1 (es) 1996-02-28 1997-02-25 Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos

Country Status (31)

Country Link
US (1) US6096714A (OSRAM)
EP (1) EP0885234B1 (OSRAM)
JP (1) JP4102440B2 (OSRAM)
KR (1) KR100486053B1 (OSRAM)
CN (1) CN1168734C (OSRAM)
AP (1) AP952A (OSRAM)
AR (1) AR005999A1 (OSRAM)
AT (1) ATE217633T1 (OSRAM)
AU (1) AU716204B2 (OSRAM)
BG (1) BG63207B1 (OSRAM)
BR (1) BR9707709B1 (OSRAM)
CZ (1) CZ293893B6 (OSRAM)
DE (1) DE69712610T2 (OSRAM)
DK (1) DK0885234T3 (OSRAM)
EA (1) EA001376B1 (OSRAM)
EE (1) EE9800265A (OSRAM)
ES (1) ES2176698T3 (OSRAM)
FR (1) FR2745290B1 (OSRAM)
HU (1) HU227567B1 (OSRAM)
IL (1) IL125622A (OSRAM)
NO (1) NO983955L (OSRAM)
NZ (1) NZ331600A (OSRAM)
OA (1) OA10845A (OSRAM)
PL (1) PL191736B1 (OSRAM)
PT (1) PT885234E (OSRAM)
SK (1) SK118498A3 (OSRAM)
TR (1) TR199801713T2 (OSRAM)
UA (1) UA58504C2 (OSRAM)
WO (1) WO1997031929A1 (OSRAM)
YU (1) YU37098A (OSRAM)
ZA (1) ZA971659B (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021870A1 (en) * 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
AU9649598A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a, 11,12-carbamate derivatives
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
IL144178A0 (en) 1999-01-27 2002-05-23 Pfizer Prod Inc Ketolide antibiotics
OA11945A (en) * 1999-05-24 2006-04-13 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
AU6316400A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6183800A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO2001010878A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
CA2703475A1 (en) * 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
EP2358379B1 (en) * 2008-10-24 2015-12-16 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
MX361413B (es) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Formas cristalinas de un macrólido y usos para las mismas.
KR101945324B1 (ko) 2010-05-20 2019-02-07 셈프라 파마슈티컬스, 인크. 매크로라이드들 및 케톨라이드들과 이의 중간체들을 제조하는 공정들
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
KR20140139083A (ko) 2012-03-27 2014-12-04 셈프라 파마슈티컬스, 인크. 마크롤라이드계 항생제를 투여하기 위한 비경구 제제
RU2015138796A (ru) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. Способы и составы для лечения респираторных заболеваний
JP6675973B2 (ja) 2013-03-15 2020-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド抗菌薬を調製するための集束的な方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487411A (en) * 1892-12-06 Island
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
ATE217633T1 (de) 2002-06-15
JP4102440B2 (ja) 2008-06-18
PL328608A1 (en) 1999-02-01
DK0885234T3 (da) 2002-08-26
OA10845A (fr) 2003-02-05
CN1212700A (zh) 1999-03-31
DE69712610D1 (de) 2002-06-20
PL191736B1 (pl) 2006-06-30
BG63207B1 (bg) 2001-06-29
SK118498A3 (en) 1999-07-12
CZ293893B6 (cs) 2004-08-18
EA199800768A1 (ru) 1999-02-25
HUP9902576A3 (en) 2001-03-28
YU37098A (sh) 1999-07-28
AP952A (en) 2001-03-29
NZ331600A (en) 1999-08-30
ES2176698T3 (es) 2002-12-01
FR2745290B1 (fr) 1998-04-03
AP9801318A0 (en) 1998-09-30
UA58504C2 (uk) 2003-08-15
JP2000505469A (ja) 2000-05-09
PT885234E (pt) 2002-10-31
WO1997031929A1 (fr) 1997-09-04
BG102691A (en) 1999-06-30
NO983955D0 (no) 1998-08-27
HU227567B1 (en) 2011-08-29
EA001376B1 (ru) 2001-02-26
FR2745290A1 (fr) 1997-08-29
TR199801713T2 (xx) 1998-12-21
BR9707709B1 (pt) 2014-10-14
KR100486053B1 (ko) 2005-06-16
EE9800265A (et) 1999-02-15
US6096714A (en) 2000-08-01
CZ258798A3 (cs) 1998-12-16
ZA971659B (en) 1998-02-26
NO983955L (no) 1998-08-27
DE69712610T2 (de) 2002-11-28
EP0885234A1 (fr) 1998-12-23
AU1929897A (en) 1997-09-16
HUP9902576A1 (hu) 1999-12-28
EP0885234B1 (fr) 2002-05-15
CN1168734C (zh) 2004-09-29
BR9707709A (pt) 1999-04-06
AU716204B2 (en) 2000-02-24
IL125622A (en) 2003-10-31
IL125622A0 (en) 1999-04-11
KR19990087324A (ko) 1999-12-27

Similar Documents

Publication Publication Date Title
AR005999A1 (es) Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos
CY1112274T1 (el) Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν
NO180538C (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
DK0578083T3 (da) Cykliske adhæsionsinhibitorer
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
HUP0001232A2 (hu) Béta-amiloid peptid kibocsátást és/vagy szintézist gátló cikloalkil-, laktám-, laktonszármazékok, és ezek tio-analógjai, valamint e vegyületeket tartalmazó gyógyászati készítmények
FI972945A0 (fi) Antigeenien antamiseen soveltuvia koostumuksia
AU7567787A (en) Taxol derivatives, their preparation and pharmaceutical compositions containing them
EP0620251A3 (en) Miscible polyolefin blends.
CO4700531A1 (es) Compuestos y composiciones que comprenden un derivado de fosfato y un vehiculo que proveen una sensacion de calenta- miento
MX9207394A (es) Esteroides de 17-espirofuran-3'-ilideno.
FI895520A0 (fi) Anti-aterosklerotiska diaryl foereningar.
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
FI913556A0 (fi) Nya piperidyletrar och -tioetrar som inhibitorer av kolesterolbiosyntes.
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
DK0564358T3 (da) 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
ES2119874T3 (es) Nuevos derivados de elipticina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE69613395D1 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel
ITRM910430A0 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego (caso 100-7655)
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2162986T3 (es) Derivados de mercapto-alcanoil-dipeptidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE282608T1 (de) Chinoxalindionen
DK0612763T3 (da) Cykliske angiopeptinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem